Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006457 |
---|---|
Receipt number | R000007663 |
Scientific Title | Phase II study of Erlotinib Plus Bevacizumab in patients with advanced Non-squamous and Non- Small Cell Lung Cancer harboring EGFR mutation who acquired resistance to prior gefitinib treatment (TAILORED-1 study) |
Date of disclosure of the study information | 2011/10/03 |
Last modified on | 2011/10/03 11:40:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/10/03 11:23:28 | ||
2 | Update | 2011/10/03 11:40:52 | Public title Public title Acronym Acronym |